These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 25157034)

  • 1. Defining disability: development and validation of a mobility-Disability Severity Index (mDSI) in Charcot-Marie-tooth disease.
    Ramchandren S; Shy M; Feldman E; Carlos R; Siskind C
    J Neurol Neurosurg Psychiatry; 2015 Jun; 86(6):635-9. PubMed ID: 25157034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Charcot-Marie-Tooth Health Index: Evaluation of a Patient-Reported Outcome.
    Johnson NE; Heatwole C; Creigh P; McDermott MP; Dilek N; Hung M; Bounsanga J; Tang W; Shy ME; Herrmann DN
    Ann Neurol; 2018 Aug; 84(2):225-233. PubMed ID: 30014533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of the Charcot-Marie-Tooth Disease Infant Scale.
    Mandarakas MR; Menezes MP; Rose KJ; Shy R; Eichinger K; Foscan M; Estilow T; Kennedy R; Herbert K; Bray P; Refshauge K; Ryan MM; Yiu EM; Farrar M; Sampaio H; Moroni I; Pagliano E; Pareyson D; Yum SW; Herrmann DN; Acsadi G; Shy ME; Burns J; Sanmaneechai O
    Brain; 2018 Dec; 141(12):3319-3330. PubMed ID: 30476010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the Italian version of the Charcot-Marie-Tooth Health Index.
    Pisciotta C; Ciafaloni E; Zuccarino R; Calabrese D; Saveri P; Fenu S; Tramacere I; Genovese F; Dilek N; Johnson NE; Heatwole C; Herrmann DN; Pareyson D;
    J Peripher Nerv Syst; 2020 Sep; 25(3):292-296. PubMed ID: 32511835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reliability and validity of the CMT neuropathy score as a measure of disability.
    Shy ME; Blake J; Krajewski K; Fuerst DR; Laura M; Hahn AF; Li J; Lewis RA; Reilly M
    Neurology; 2005 Apr; 64(7):1209-14. PubMed ID: 15824348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translation and cross-cultural adaptation of the Charcot-Marie-Tooth disease Pediatric Scale to Brazilian Portuguese and determination of its measurement properties.
    Cruz KLT; Camargos ACR; Cardoso J; de Baptista CRJA; Ramos AD; Mattiello-Sverzut AC; Burns J; Leite HR
    Braz J Phys Ther; 2021; 25(3):303-310. PubMed ID: 32800672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the Charcot-Marie-Tooth disease pediatric scale as an outcome measure of disability.
    Burns J; Ouvrier R; Estilow T; Shy R; Laurá M; Pallant JF; Lek M; Muntoni F; Reilly MM; Pareyson D; Acsadi G; Shy ME; Finkel RS
    Ann Neurol; 2012 May; 71(5):642-52. PubMed ID: 22522479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of muscle strength, balance and functionality of individuals with type 2 Charcot-Marie-Tooth Disease.
    de França Costa IMP; Nunes PS; de Aquino Neves EL; Lima Santos Barreto LC; Garcez CA; Souza CC; Pereira Oliveira PM; Sales Ferreira LA; Brandão Lima VN; de Souza Araújo AA
    Gait Posture; 2018 May; 62():463-467. PubMed ID: 29674285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The application of scales and characteristics of disability in the common genotypes of Charcot-Marie-Tooth disease].
    Liu X; Zhang RX; Liu L; Xie YZ; Lin ZQ; Zhao Q; Cao WQ; Zhu XY; Li XB
    Zhonghua Yi Xue Za Zhi; 2021 Jan; 101(2):131-136. PubMed ID: 33455129
    [No Abstract]   [Full Text] [Related]  

  • 10. Reliability and validity of the Manual Ability Measure-36 in persons with Charcot-Marie-Tooth disease.
    Poole JL; Huffman M; Hunter A; Mares C; Siegel P
    J Hand Ther; 2015; 28(4):364-7; quiz 368. PubMed ID: 26318522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early onset severe and late-onset mild Charcot-Marie-Tooth disease with mitofusin 2 (MFN2) mutations.
    Chung KW; Kim SB; Park KD; Choi KG; Lee JH; Eun HW; Suh JS; Hwang JH; Kim WK; Seo BC; Kim SH; Son IH; Kim SM; Sunwoo IN; Choi BO
    Brain; 2006 Aug; 129(Pt 8):2103-18. PubMed ID: 16835246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Validation of the Pediatric Charcot-Marie-Tooth Disease Quality of Life Outcome Measure.
    Ramchandren S; Wu TT; Finkel RS; Siskind CE; Feely SME; Burns J; Reilly MM; Estilow T; Shy ME;
    Ann Neurol; 2021 Feb; 89(2):369-379. PubMed ID: 33222249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-reported physical activity in people with limb-girdle muscular dystrophy and Charcot-Marie-Tooth disease in Norway.
    Andries A; van Walsem MR; Frich JC
    BMC Musculoskelet Disord; 2020 Apr; 21(1):235. PubMed ID: 32284057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reliability of the Charcot-Marie-Tooth functional outcome measure.
    Bray P; Cornett KMD; Estilow T; Pareyson D; Zuccarino R; Skorupinska M; Pipis M; Sowden JE; Scherer S; Reilly MM; Shy ME; Herrmann DN; Burns J; Eichinger KJ
    J Peripher Nerv Syst; 2020 Sep; 25(3):288-291. PubMed ID: 32844461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variables influencing quality of life and disability in Charcot Marie Tooth (CMT) patients: Italian multicentre study.
    Padua L; Aprile I; Cavallaro T; Commodari I; La Torre G; Pareyson D; Quattrone A; Rizzuto N; Vita G; Tonali P; Schenone A;
    Neurol Sci; 2006 Dec; 27(6):417-23. PubMed ID: 17205227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome measures for Charcot-Marie-Tooth disease: clinical and neurofunctional assessment in children.
    Pagliano E; Moroni I; Baranello G; Magro A; Marchi A; Bulgheroni S; Ferrarin M; Pareyson D
    J Peripher Nerv Syst; 2011 Sep; 16(3):237-242. PubMed ID: 22003938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Motor unit number index correlates with disability in Charcot-Marie-Tooth disease.
    Bas J; Delmont E; Fatehi F; Salort-Campana E; Verschueren A; Pouget J; Lefebvre MN; Grapperon AM; Attarian S
    Clin Neurophysiol; 2018 Jul; 129(7):1390-1396. PubMed ID: 29729594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Charcot-Marie-Tooth and pain: correlations with neurophysiological, clinical, and disability findings.
    Padua L; Cavallaro T; Pareyson D; Quattrone A; Vita G; Schenone A;
    Neurol Sci; 2008 Jun; 29(3):193-4. PubMed ID: 18612771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Charcot-Marie-Tooth Functional Outcome Measure (CMT-FOM).
    Eichinger K; Burns J; Cornett K; Bacon C; Shepherd ML; Mountain J; Sowden J; Shy R; Shy ME; Herrmann DN
    Neurology; 2018 Oct; 91(15):e1381-e1384. PubMed ID: 30232254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Foot Function Index: A Promising Questionnaire for Individuals With Charcot-Marie-Tooth Disease Type 1A.
    Bihel L; Reynaud V; Givron P; Clavelou P; Cornut-Chauvinc C; Pereira B; Thomas E; Taithe F; Coudeyre E
    Arch Phys Med Rehabil; 2019 Dec; 100(12):2403-2406. PubMed ID: 31255638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.